Issue 36

CPHI Americas 2025: Your Event Review and Frankfurt Sneak Peek

Why not sign up for our future email newsletters? Sign up here.

Included in this issue:

LEAD STORY

Reflecting on a Transformative Event for the Americas Pharma Market

CPHI Americas has wrapped for 2025, closing its doors at noon (EST) on May 22 after having welcomed over 3,925 attendees and 370 exhibitors, as well as 16 start-ups and 82 speakers. This year’s show, which was renamed to be more representative of the broader audience of the U.S., South America, and Canada, featured an expanded conference agenda with five tracks, a new bioproduction zone, the return of the Start-Up Market for its second year, and included highlights of the Latin American market, as well as much more.

In this brief event review, The Pharma Navigator provides a capsule look at some of our key highlights from CPHI Americas 2025 and reveal some exciting news about CPHI Frankfurt too. Click below to read more…

Read more here.

FEATURED STORIES

CDMO Forms Strategic Collaborations for Cell-Based Therapies in Eye Disease and Solid Tumors

Read more here.

Novavax’s Jab Gets FDA Approval

Read more here.

Regeneron to Purchase Bankrupt DNA Testing Firm

Read more here.

Novo Nordisk CEO Steps Down

Read more here.

Ecolab Opens New Bioprocessing Lab in Eastern U.S.

Read more here.

GSK Acquires Promising Liver Disease Drug in USD 2 Billion Deal

Read more here.

New Data Demonstrates Unique Expression Profile of RNA Platform

Read more here.